Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis.

Winters, Z E; Hunt, N C; Bradburn, M J; Royds, J A; Turley, H; Harris, A L; Norbury, C J

Winters, Z E; Hunt, N C; Bradburn, M J; Royds, J A; Turley, H; Harris, A L; Norbury, C J.

Affiliation

Winters ZE; Imperial Cancer Research Fund Molecular Oncology Laboratory, University of Oxford Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK.

Eur J Cancer ; 37(18): 2405-12, 2001 Dec.

Article in En | MEDLINE | ID: mdl-11720835

Subject(s)

Breast Neoplasms/chemistry; CDC2 Protein Kinase/analysis; Carcinoma, Ductal, Breast/chemistry; Cyclin B/analysis; Cyclins/analysis; Neoplasm Proteins/analysis; Adult; Aged; Aged, 80 and over; Cyclin-Dependent Kinase Inhibitor p21; Disease-Free Survival; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local/chemistry; Predictive Value of Tests; Tumor Suppressor Protein p53/analysis

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / CDC2 Protein Kinase / Cyclins / Carcinoma, Ductal, Breast / Cyclin B / Neoplasm Proteins Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Middle aged Language: En Journal: Eur J Cancer Year: 2001 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links